TrialClinical and molecular hepatology2026

Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production.

Dianji Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.